Cargando…
New perspective in heart failure management: could myosin activators be the answer?
Heart failure is a worldwide leading cause of hospital admissions. There is a critical need for new methods of management in acute heart failure. The current drug panel available in the treatment of hemodinamically unstable patients is not only limited, but it is also associated with deleterious sid...
Autores principales: | Andrei, Stefan, Iorgoveanu, Corina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Applied Systems srl
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941581/ https://www.ncbi.nlm.nih.gov/pubmed/32309560 http://dx.doi.org/10.15190/d.2014.25 |
Ejemplares similares
-
Heart Failure Pharmacological Management: Gaps and Current Perspectives
por: Severino, Paolo, et al.
Publicado: (2023) -
Keeping up with the COVID's—Could siRNA‐based antivirals be a part of the answer?
por: Forgham, Helen, et al.
Publicado: (2022) -
Translation of Cardiac Myosin Activation With 2-Deoxy-ATP to Treat Heart Failure Via an Experimental Ribonucleotide Reductase-Based Gene Therapy
por: Thomson, Kassandra S., et al.
Publicado: (2016) -
Diversity is the question, not the answer
por: Shade, Ashley
Publicado: (2017) -
Why did the dinosaurs become extinct? Could cholecalciferol (vitamin D(3)) deficiency be the answer?
por: Fraser, D. R.
Publicado: (2019)